You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
TOPIC 356: FLOUROGENIC ASSAY PLATFORM FOR CIRCULAR RNA DETECTION
SBC: LUCERNA INC Topic: NCICircular RNAs (circRNAs) are a novel class of non-coding RNAs that are an abundant component of the epitranscriptome. Putative functions of circRNAs, include miRNA sequestration, RNA-binding protein scaffolding, mRNA trapping, and protein translation regulation. Deregulation in one or more of these roles has been linked to several types of cancer, including pancreatic cancer, basal cell carcinoma, ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 374: Topical Delivery of Nanoformulated Bioactive Chemopreventive Agent in Skin Cancer
SBC: VASCULAR VISION PHARMACEUTICAL CO Topic: NCIWe plan to evaluate the chemopreventive management of solar ultraviolet (UV) mediated DNA damage by two different Nanoformulation of epigallicatechin-3-gallate (EGCG). The formulations to be assessed under this study include: a) chitosan based formulation of EGCG (nano-EGCG), and b) EGCG containing chitosan based solid lipid nanoparticles (E-Ch-SLNPs). EGCG is well-tested and popular polyphenol in ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 341: Open Scalable Software Infrastructure for Metabolomics Data
SBC: KITWARE INC Topic: NCIMetabolomics research has great potential, and researchers are rapidly producing new techniques for analyzing the large quantities of measurement data in order to utilize metabolomic data more effectively, including promising techniques for data integration across multiple modalities of data from mass spectrometry (MS) and nuclear magnetic resonance (NMR). However, this confluence of data growth a ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
STEM and Health: Science Kits Integrating STEM Concepts with Human Health
SBC: Science Take-Out, LLC Topic: 500ABSTRACT Solving human health problems often involves technologies developed through the collaborative work of scientistsengineersand mathematiciansDespite the fact that STEMsciencetechnologyengineeringand mathematicscollaboration is a crucial aspect of medical research and healthcare careersmany students are still learning scienceengineeringand math as isolated disciplinesIn additionmany teachers ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of KLS-13019 for Chemotherapy Induced Peripheral Neuropathy and Drug Dependence
SBC: KannaLife Sciences Inc. Topic: NIDAChemotherapy induced peripheral neuropathyCIPNcan be a chronicseverely debilitating consequence of cancer therapy for which there are no effective management strategiesMoreoverupwards ofof CIPN patients reported using prescription opioids for pain management despite the fact that there is only weak evidence that long term continuation of opioids provides clinically significant pain relief in these ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Tailored Approach to Promoting Engagement in Public Health
SBC: Transcendent International, LLC Topic: NINRPROJECT SUMMARY Successfully reaching and enrolling fully representative target populations in public health interventions is a highly desiredbut notoriously difficultprospectespecially when an initiative is focused on socially charged issues or health conditions that affect vulnerable subgroupsFor exampleHIV AIDS has disproportionately high morbidity among a number of minority marginalized popula ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA
SBC: Calder Biosciences Inc. Topic: NIAAn Influenza pandemic remains an acute threat to world health; and stockpiling a universally protective Influenza vaccine provides a strong defense against this potential catastrophe. The hemagglutinin (HA) protein is the primary target of humoral Ab responses to Influenza; the majority of broadly protective mAbs (bnAbs) against influenza isolated from humans recognize conserved and conformation-s ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Effect of Repeated Administration of G-CSF on Hot Flashes and Other Vasomotor Symptoms of Menopause
SBC: MENOGENIX, INC. Topic: NIAOne of the most common and distressing symptoms of menopause are hot flashesHot flashes and related symptoms represent a significant unmetworldwidehealthcare neednot only in women after surgical or natural menopausebut also in breast and prostate cancer patients undergoing hormone suppression or ablationHot flashes occur inof women undergoing natural menopause and approximatelymillion individuals ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
MtLDL detection to diagnose childhood tuberculosis
SBC: CHRONUS PHARMACEUTICALS, INC. Topic: NIAIDProject SummaryChildhood TB is estimated to contributeof the disease burden in high burden settingswith approximately a million cases per year inworldwideExisting gold standard diagnostic culture tools fail to confirm TB in most childrenwho typically have low bacterial counts and cannot produce sputumMore sensitive and child friendly diagnostic tools are urgently needed to diagnose TB in childrenC ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A novel nutraceutical drug for tendinopathy treatment
SBC: NEW YORK R & D CENTER FOR TRANSLATIONAL MEDICINE & THERAPEUTICS INC Topic: NCCIHPROJECT SUMMARYThis study aims to prove the concept and feasibility that oral administration of Ea product formulated from a combination of generally regarded as safe compoundsGRASexerts therapeutic efficacy on tendinopathyTendinopathy is a common chronic tendon disorder that affects young athletes andof individuals overyears oldIt is characterized by painswellingloss of functionand impaired perfo ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health